As lead negotiator in #IP,🇨🇭should stop requesting #TRIPS+ provisions (patent term extension, data exclusivity, weakening of #TRIPS flexibilities) in the #EFTA-Thailand free trade agreement, as these will affect access to lifesaving medicines Guy Parmelin SECO EFTA Secretariat

💊 La multiplication des #brevets sur les médicaments est-elle vraiment synonyme d’innovation ? 👀 On en parle dans le #podcast «Mon œil!» avec Patrick Durisch (@dbdurisch.bsky.social), responsable santé chez Public Eye ▶ youtu.be/ep-cwDd9DuY

Retrouvez «Mon œil! Le #podcast engagé de Public Eye» sur Youtube ▶ youtu.be/ep-cwDd9DuY ou en version audio sur votre app préférée 🎧 peye.link/applis

Merck’s CEO intentionally misled Senator Ben Ray Luján when he said he wouldn't stop a biosimilar “IV version” of Keytruda. This is why. Merck had already patented another version of Keytruda they were testing. Now they can easily shift patients over to it to protect their monopoly.

EU must stop pushing for TRIPS plus measures in bilateral trade agreements.

Légaliser les rabais secrets sur les médicaments en les excluant de la #LTrans créerait un dangereux précédent. Le CN en débat à nouveau lundi, Public Eye l'intime de suivre sa commission santé et de biffer l'art. 52c du paquet de maîtrise des coûts tdg.ch/pharma-les-pri…

Geheimrabatte auf überhöhte Medikamentenpreise zu legalisieren wäre ein gefährlicher Präzedenzfall für das Öffentlichkeitsgesetz. Der Nationalrat muss nächsten Montag seine Gesundheitskommission folgen und Art. 52c der KVG-Revision ganz einfach streichen tagesanzeiger.ch/umstrittene-ge…

Patented drug prices are major drivers of🇨🇭health insurance expenses (3/4 of total prescription drug costs). But instead of requiring > transparency on #BigPharma real R&D costs to set fair prices,🇨🇭wants to legalise #secretrebates, in total contradiction with resolution WHA72.8

NEW: Public Citizen reveals the billions of 💰 drug companies have extracted from Medicare by abusing the patent system to hike drug prices. Medicare must heavily weigh the costs of patent abuse when negotiating maximum fair prices. citizen.org/article/using-…

A coalition of Swiss NGOs led by Public Eye requested today🇨🇭Helene Budliger Artieda Guy Parmelin to drop harmful #TRIPS+ provisions contained in the free trade deal between EFTA Secretariat🇳🇴🇨🇭🇮🇸 🇱🇮 and Malaysia 🇲🇾 that threaten the rights to health & to food publiceye.ch/en/news/detail…

#BewareOfMeepa Leaked text of Malaysia’s trade deal with EFTA reveals push for TRIPS+ Anwar Ibrahim Tengku Zafrul 🇲🇾 Dzulkefly Ahmad This will lock 🇲🇾 into expanded patent monopolies & strip away critical legal @WTO flexibilities See Consumers Association Penang's analysis ▶️tinyurl.com/3ds9md43

Even Swiss civil society is echoing #BewareOfMEEPA 🇨🇭Prominent Swiss CSOs, like Public Eye, urged their govt to stop pushing Malaysia into IP rules that threaten access to medicines & seeds “Switzerland imperils the rights to food and health” publiceye.ch/en/news/detail…